APA Alıntı

Tan, N. Y., Deng, Y., Yao, X., Sangaralingham, L. R., Shah, N. D., Rule, A. D., . . . Sangaralingham, S. J. (2021). Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker. Mayo Clin Proc Innov Qual Outcomes.

Chicago Stili Alıntı

Tan, Nicholas Y., Yihong Deng, Xiaoxi Yao, Lindsey R. Sangaralingham, Nilay D. Shah, Andrew D. Rule, John C. Burnett, Shannon M. Dunlay, ve S. Jeson Sangaralingham. "Renal Outcomes in Patients With Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker." Mayo Clin Proc Innov Qual Outcomes 2021.

MLA Alıntı

Tan, Nicholas Y., et al. "Renal Outcomes in Patients With Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker." Mayo Clin Proc Innov Qual Outcomes 2021.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..